$80.35
2.74%
Nasdaq, Oct 16, 04:00 pm EDT. Closed.
ISIN
US8935291075
Symbol
TRNS

Transcat, Inc. Stock price

$80.35
-3.29 3.93% 1M
+3.88 5.07% 6M
+23.62 41.64% YTD
+10.45 14.95% 1Y
-13.82 14.68% 3Y
+9.81 13.91% 5Y
+70.10 683.90% 10Y
+74.95 1,387.96% 20Y
Nasdaq, Closing price Fri, Oct 16 2026
-2.26 2.74%
ISIN
US8935291075
Symbol
TRNS
Sector

Is Transcat, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,109 stocks worldwide.

Key metrics

Basic
Market capitalization
$752.1m
Enterprise Value
$855.8m
Net debt
$103.8m
Cash
$6.7m
Shares outstanding
9.4m
Valuation
P/E
223.2
P/S | estimate
2.2 | 2.0
EV/Sales | estimate
2.5 | 2.2
EV/FCF | ex SBC
33.7 | 50.5
P/B
2.5
Financial Health
Equity Ratio
62.6%
Return on Equity
1.8%
ROCE
3.6%
ROIC
2.2%
Debt/Equity
0.4
Share-Based Compensation & Dilution
SBC | % of Revenue
$8.4m | 2.4%
SBC as % of FCF
33.1%
SBC Growth 1Y
128.3%
Share Count Growth 1Y
0.4%
Shareholder Yield
-0.4%
Financials
Revenue | estimate
$348.4m | $381.0m
EBITDA
$44.0m
EBIT
$16.4m
Net Income
$3.5m
Free Cash Flow | ex SBC
$25.4m | $17.0m
Growth
Revenue | estimate
20.9% | 14.8%
EBITDA
12.5%
EBIT
-13.6%
Net Income
-74.2%
Free Cash Flow
29.7%
Margin
Gross
32.5%
EBITDA
12.6%
EBIT
4.7%
Net
1.0%
Free Cash Flow | ex SBC
7.3% | 4.9%
More
EPS
$0.4
FCF per Share
$2.7
Short interest
6.4%
Employees
1k
Rev per Employee
$230.0k

Transcat, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Transcat, Inc. forecast:

7x Buy
70%
3x Hold
30%

Analyst Opinions

10 Analysts have issued a Transcat, Inc. forecast:

Buy
70%
Hold
30%

Transcat, Inc. Events

Past Events
AUG
4
Q1 2027 Earnings Call
2 months ago
MAY
26
Q4 2026 Earnings Call
5 months ago
FEB
3
Q3 2026 Earnings Call
9 months ago
NOV
3
Q2 2026 Earnings Call
12 months ago

Financial data from Transcat, Inc.

Jun '26
+/-
%
348 348
21% 21%
100%
- Direct Costs 235 235
20% 20%
68%
113 113
22% 22%
32%
- Selling and Administrative Expenses 97 97
31% 31%
28%
- Research and Development Expense - -
-
-
44 44
13% 13%
13%
- Depreciation and Amortization 28 28
37% 37%
8%
EBIT (Operating Income) EBIT 16 16
14% 14%
5%
Net Profit 3.45 3.45
74% 74%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Transcat, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Transcat, Inc. Stock News

Neutral
Business Wire
●
about 2 months ago
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical.
Neutral
Business Wire
●
2 months ago
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat Reports Strong Fiscal First Quarter 2027 Results with Double-Digit Service Organic Revenue Growth and Service Gross Margin Expansion.
More Transcat, Inc. News

Company Profile

Transcat, Inc. engages in provision of calibration and laboratory instrument services. It operates through Service and Distribution segments. The Service segment offers calibration, repair, inspection, analytical qualifications, preventive maintenance, consulting, and other related services. The Distribution segment distributes professional grade test, measurement, and control instrumentation. The company was founded in 1964 and is headquartered in Rochester, NY.

Head office United States
CEO Mr. Rudow
Employees 1,413
Founded 1964
Website www.transcat.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today